Varex Imaging Corporation (VREX)

Varex Imaging Corp.'s stock has seen a 48.96% change over the past year, with a 52-week range between $6.76 and $14.57. In March 2026, Varex completed debt refinancing, reducing debt and interest expense. On May 7, 2026, Varex announced revenues of $216 million for Q2 fiscal year 2026, a 1% increase year-over-year, and an adjusted EPS of $0.21, which met consensus estimates. The GAAP net loss was $0.19 per diluted share. Insider selling activity totaling approximately $90,645 has been reported in the past 12 months.

Recent statements from the company's CEO indicate solid demand in the second quarter of fiscal year 2026, with continued momentum across both Medical and Industrial segments. The company anticipates favorable demand trends for the second half of fiscal 2026, suggesting relatively consistent demand.

Varex Imaging Corp. is an innovator, designer, and manufacturer of X-ray imaging components for medical, security, and industrial applications. The company's products include X-ray tubes, detectors, linear accelerators, software, connectors, and other components integrated into systems by OEMs and sold directly to end-users.

Varex Imaging Corp. has a global presence with approximately 2,400 employees and facilities in North America, Europe, and Asia. The company's products are sold across the Americas, EMEA, and APAC regions.

Varex Imaging Corp.'s recent financial reports indicate solid demand and continued momentum across its Medical and Industrial businesses. The company is investing in AI-enabled imaging and photon counting technology, suggesting a commitment to innovation.

Varex Imaging Corp.'s ownership is predominantly held by institutional investors, who hold approximately 40.36% of the company's stock. Insiders hold about 1.57%. Major institutional owners include Pzena Investment Management Llc, BlackRock, Inc., and Vanguard Group Inc, among others.